- Home
- SDOT vs SABS Comparison
SDOT vs SABS Comparison
Compare SDOT & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDOT
- SABS
- Stock Information
- Founded
- SDOT 2014
- SABS 2014
- Country
- SDOT United States
- SABS United States
- Employees
- SDOT N/A
- SABS N/A
- Industry
- SDOT Restaurants
- SABS Biotechnology: Pharmaceutical Preparations
- Sector
- SDOT Consumer Discretionary
- SABS Health Care
- Exchange
- SDOT Nasdaq
- SABS Nasdaq
- Market Cap
- SDOT 16.5M
- SABS 19.0M
- IPO Year
- SDOT 2020
- SABS N/A
- Fundamental
- Price
- SDOT $2.68
- SABS $1.19
- Analyst Decision
- SDOT
- SABS Strong Buy
- Analyst Count
- SDOT 0
- SABS 5
- Target Price
- SDOT N/A
- SABS $11.40
- AVG Volume (30 Days)
- SDOT 17.5K
- SABS 38.1K
- Earning Date
- SDOT 05-14-2025
- SABS 05-19-2025
- Dividend Yield
- SDOT N/A
- SABS N/A
- EPS Growth
- SDOT N/A
- SABS N/A
- EPS
- SDOT 0.85
- SABS N/A
- Revenue
- SDOT $700,937,000.00
- SABS $1,322,410.00
- Revenue This Year
- SDOT $12.76
- SABS N/A
- Revenue Next Year
- SDOT $5.54
- SABS $25.00
- P/E Ratio
- SDOT $3.13
- SABS N/A
- Revenue Growth
- SDOT N/A
- SABS N/A
- 52 Week Low
- SDOT $2.24
- SABS $1.11
- 52 Week High
- SDOT $7.00
- SABS $5.01
- Technical
- Relative Strength Index (RSI)
- SDOT 32.58
- SABS 31.84
- Support Level
- SDOT $2.54
- SABS $1.11
- Resistance Level
- SDOT $2.69
- SABS $1.80
- Average True Range (ATR)
- SDOT 0.12
- SABS 0.16
- MACD
- SDOT -0.03
- SABS -0.01
- Stochastic Oscillator
- SDOT 7.56
- SABS 19.74
About SDOT Sadot Group Inc.
Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China, and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.